Trial Profile
Phase I Study of Ixabepilone and Temsirolimus in Adult Patients With Advanced Solid Tumors
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 15 Mar 2024
Price :
$35
*
At a glance
- Drugs Ixabepilone (Primary) ; Temsirolimus (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 05 Dec 2016 Planned primary completion date changed from 1 Jun 2016 to 1 Jun 2017.
- 05 Dec 2016 Planned primary completion date changed from 1 Jun 2016 to 1 Jun 2017.
- 09 Nov 2015 Results presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2015